Full Year Results 

Dechra hikes dividend

Dechra hikes dividend

Management at Dechra Pharmaceuticals (DPH) cited a “resilient” full-year performance, notwithstanding Covid-19 disruption in recent months. That sentiment was borne out by the veterinary healthcare group’s preliminary figures, with operating profits climbing by a third. This, together with a cash conversion ratio of 99.4 per cent, underpinned an 8.5 per cent dividend hike – serving up a reminder of Dechra’s defensive qualities.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now